Global health surveillance data through mid-2026 shows no novel coronavirus strains meeting the transmissibility and virulence thresholds for pandemic emergence, supporting the 94.7% market-implied probability of no new outbreak this year. Official monitoring by the CDC and WHO continues to track SARS-CoV-2 variants alongside other respiratory pathogens, with case counts remaining at endemic levels and no reported animal-to-human spillovers exhibiting sustained human transmission. Historical patterns post-2020 indicate that major coronavirus pandemics arise infrequently, often requiring specific genetic adaptations and favorable ecological conditions that current genomic sequencing has not detected. Traders appear to weigh this baseline stability heavily, though an unexpected mutation enabling immune escape or a new zoonotic event could rapidly shift odds if confirmed by public health agencies.